Overview Financials News + Filings Key Docs Charts Holdings Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Inv. presentation
Quarterly results
Director departure
Appointed director
|
|
Acer Therapeutics Inc. (ACER)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 03/29/2021 |
GN
| Acer Therapeutics to Participate in Needham Virtual Healthcare Conference |
| 03/25/2021 |
GN
| Notice of Settlement of Derivative Suits |
| 03/22/2021 |
GN
| Relief and Acer Therapeutics Sign Collaboration and License Agreement for Worldwide Development and Commercialization of ACER-001 for the Treatment of Urea Cycle Disorders and Maple Syrup Urine Disease |
| 03/01/2021 |
GN
| Acer Therapeutics Reports Fourth Quarter and Full Year 2020 Financial Results and Provides Corporate Update |
| 02/11/2021 |
GN
| Acer Therapeutics Announces Topline Results from its Bioequivalence Trial of ACER-001 Compared to BUPHENYL® Under Fed Conditions |
| 01/25/2021 |
GN
| Relief Therapeutics and Acer Therapeutics Sign Option Agreement for Exclusivity to Negotiate a Collaboration and License Agreement for the Worldwide Development and Commercialization of ACER-001 for the Treatment of Urea Cycle Disorders and Maple Syrup Urine Disease |
| 12/22/2020 |
GN
| Acer Therapeutics Announces Full Enrollment of Pivotal Bioequivalence Trial of ACER-001 for Urea Cycle Disorders |
| 12/17/2020 |
GN
| Acer Therapeutics Announces Publication of Vascular Ehlers-Danlos Syndrome (vEDS) Patient Registry Data from Sweden |
| 10/01/2020 |
GN
| Acer Therapeutics to Present at the Virtual BIO Investor Forum Digital |
| 08/25/2020 |
GN
| Acer Therapeutics to Virtually Present at Upcoming Investor Conferences |
| 07/23/2020 |
GN
| Acer Therapeutics Investors Who Have Held Their Stock Continuously Since at Least September 25, 2017 Are Encouraged to Contact Kehoe Law Firm, P.C. |
| 05/11/2020 |
GN
| Acer Therapeutics to Develop Emetine as Potential COVID-19 Treatment in Collaboration with National Center for Advancing Translational Sciences, One of the National Institutes of Health |
| 03/18/2020 |
GN
| Acer Receives Formal Dispute Resolution Request (FDRR) Response from FDA's Office of New Drugs |
| 03/18/2020 |
GN
| Acer Therapeutics Reports Fourth Quarter and Full Year 2019 Financial Results and Provides Corporate Update |
| 02/24/2020 |
GN
| Acer Therapeutics Announces ACER-001 for Urea Cycle Disorders Trial Shows Bioequivalence to BUPHENYL® |
| 01/28/2020 |
GN
| Bragar Eagel & Squire is Investigating Certain Officers and Directors of Baxter International, Acer Therapeutics, iRobot, and Prudential Financial and Encourages Investors to Contact the Firm |
| 12/05/2019 |
GN
| Bragar Eagel & Squire is Investigating Certain Officers and Directors of Acer Therapeutics, Mammoth Energy, ProPetro, and Eldorado Resorts and Encourages Investors to Contact the Firm |
| 09/11/2019 |
GN
| Bragar Eagel & Squire is Investigating Certain Officers and Directors of Mammoth Energy, Acer Therapeutics, Realogy Holdings, and AxoGen and Encourages Investors to Contact the Firm |
| 08/30/2019 |
GN
| FINAL DEADLINE - Acer Therapeutics Inc. (ACER) - Bronstein, Gewirtz & Grossman, LLC Reminds Shareholders of Class Action and Lead Plaintiff Deadline: August 30, 2019 |
| 08/29/2019 |
GN
| KESSLER TOPAZ MELTZER & CHECK, LLP: Final Deadline Reminder for ACER THERAPEUTICS, INC. Investors – ACER |
| 08/29/2019 |
GN
| SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Acer Therapeutics, Inc. of Class Action Lawsuit and Upcoming Deadline – ACER |
| 08/27/2019 |
GN
| Acer Therapeutics to Present at the 21st Annual H.C. Wainwright Global Investment Conference |
| 08/26/2019 |
GN
| Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Fred's, Acer Therapeutics, Diebold Nixdorf, and Intelligent Systems and Encourages Investors to Contact the Firm |
| 08/23/2019 |
GN
| Glancy Prongay & Murray Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Acer Therapeutics Inc. |
| 08/23/2019 |
GN
| Deadline Reminder: Law Offices of Howard G. Smith Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Acer Therapeutics Inc. |
| 08/21/2019 |
GN
| Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Sunlands Technology Group, Fred's, Acer Therapeutics, and Ideanomics and Encourages Investors to Contact the Firm |
| 08/20/2019 |
GN
| SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Acer Therapeutics, Inc. of Class Action Lawsuit and Upcoming Deadline – ACER |
| 08/19/2019 |
GN
| Kessler Topaz Meltzer & Check, LLP - Important Deadline Reminder for Acer Therapeutics, Inc. Investors |
| 08/16/2019 |
GN
| FDX, ACER & DBD Class Action - Bronstein, Gewirtz & Grossman, LLC |
| 08/15/2019 |
GN
| Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Pivotal Software, Sunlands, Fred's, and Acer Therapeutics and Encourages Investors to Contact the Firm |
| 08/15/2019 |
GN
| SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Acer Therapeutics, Inc. of Class Action Lawsuit and Upcoming Deadline – ACER |
| 08/13/2019 |
GN
| Acer Therapeutics Reports Second Quarter 2019 Financial Results and Provides Corporate Update |
| 08/09/2019 |
GN
| SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Acer Therapeutics, Inc. of Class Action Lawsuit and Upcoming Deadline – ACER |
| 08/09/2019 |
GN
| FDX, ACER & DBD Class Action - Bronstein, Gewirtz & Grossman, LLC |
|
|
|